... Human blood substitutes were originally conceived as a vehicle to treat wounded soldiers in battlefield settings. By 1998, several companies appeared to be on the verge of viable blood substitute called "hemoglobin-based blood substitutes." These products were developed to exploit the natural oxygen-carrying capabilities of hemoglobin. Some of the products strengths were that it was "universal" needing no blood typing, they were free of infectious agents, they have an increased shelf life of 2 years compared with 6 weeks for donated blood, and as with Biopure's line, require no refrigeration (Dolan, 1997). Competitive Analysis Biopure has two target markets at this time. The veterinary market. The market in this area consists of primary provider veterinarians and clinics, emergency clinics, pet owners, and of course pets. After FDA approval, they will expand into the human market of hospitals, clinics, primary providers, patients, insurance companies. Insurance companies will also set reimbursement, so it ...

See this essay or coursework document in full right now